×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Arovella Therapeutics to raise funds for trial of lymphoma drug
Clinical Trials Arena
Arovella Therapeutics has announced plans to raise around A$12.5m ($8.1m) to begin Phase I clinical trials of its drug candidate ALA-101.
1 month ago
Arovella Therapeutics Updates Trading Policy - TipRanks.com
Tipranks
Arovella Therapeutics Limited (AU:ALA) has released an update. Arovella Therapeutics Limited has announced an update to its Share Trading Policy effective...
2 weeks ago
We Might See A Profit From Arovella Therapeutics Limited (ASX:ALA) Soon
Yahoo Finance
Arovella Therapeutics is bordering on breakeven, according to some Australian Pharmaceuticals analysts. They anticipate the company to incur a...
6 months ago
Arovella Therapeutics (ASX:ALA) shareholders are still up 335% over 1 year despite pulling back 19% in the past week
Simply Wall Street
Arovella Therapeutics Limited ( ASX:ALA ) shareholders might be concerned after seeing the share price drop 19% in the...
2 months ago
Arovella Acquires License for New CARiNKT Cell Armouring Tech
Mirage News
Arovella Therapeutics (ASX:ALA) has signed a global, exclusive license agreement with the University of North Carolina Lineberger...
3 months ago
SparX and Arovella partner to develop CAR-iNKT cell therapy
Pharmaceutical Technology
SparX's monoclonal antibody was used to develop the Claudin 18.2 tumour-specific antigen targeting CAR-iNKT cell therapy.
7 months ago
ALA is our best performing stock in 2023 - here's why, and what to expect in 2024
Next Investors
The best stock in our portfolio this year was Arovella Therapeutics (ASX: ALA), growing 475% since the start of the year.
4 months ago
Arovella Therapeutics Strengthens Cancer Therapy Platform - TipRanks.com
Tipranks
Arovella Therapeutics Limited (AU:ALA) has released an update. Arovella Therapeutics Limited has fortified its financial and technological position in the...
2 weeks ago
Arovella Therapeutics appoints CAR-iNKT cell pioneer to Scientific Advisory Board
Proactive Investors
Arovella Therapeutics Ltd (ASX:ALA), a biotechnology company focused on developing its invariant Natural Killer T (iNKT) cell therapy...
1 month ago